Immunization of BALB/cJ mice with a peptide corresponding to residues 1 to 23 of glycoprotein D [gD(1–23)] from herpes simplex virus type 2 (HSV-2) elicits antibody responses which correlate with protection against lethal HSV-2 infection. In the present study, we examined the ability of cholera toxin (CTX) to act as an immunogenic carrier for gD(1–23). The number of gD(1–23) residues conjugated to CTX affected its binding to GM1 ganglioside and physiological toxicity, both of which are factors affecting oral immunogenicity. The antibody response elicited after intraperitoneal (i.p.) immunization with the CTX-gD(1–23) conjugate was protective against a lethal i.p. challenge with HSV-2. In other experiments, mice were immunized i.p. on day 0 and subsequent immunizations conducted on days 14 and 28 were administered either intragastrically or intravaginally (i.vag.). Intraperitoneal priming followed by either i.p. or intragastric boosting resulted in anti-HSV-2 antibodies in vaginal washings and in protection against a lethal i.vag. challenge with HSV-2. Intraperitoneal priming followed by i.vag. boosting did not elicit anti-HSV-2 antibodies in vaginal washings and did not protect mice against a lethal i.vag. challenge with HSV-2. These results suggest that CTX can act as a systemic and an oral delivery molecule for the covalently linked gD(1–23) peptide and that such conjugates can elicit protective immune responses against systemic and genital HSV-2 infection.
BalachandranN.,
BacchettiS.,
RawlsW. E.1982; Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infection and Immunity 37:1132–1137
BattyI.,
WarrackG. H.1955; Local antibody production in the mammary gland, spleen, uterus, vagina and appendix of the rabbit. Journal of Pathology and Bacteriology 70:335–355
BermanP. W.,
VogtP. E.,
GregoryT.,
LaskyL. A.,
KernE. R.1988; Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs. Journal of Infectious Disease 157:897–902
BrynestadK.,
BabbittB.,
HuangL.,
RouseB. T.1990; Influence of peptide acylation on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines. Journal of Virology 64:680–685
BuckmasterE. A.,
GompelsU.,
MinsonA. C.1984; Characterization and physical mapping of an HSV-1 glycoprotein of approximately 115 × 103 molecular weight. Virology 139:408–413
ChipperfieldE. J.,
EvansB. A.1972; The influence of local infection on immunoglobulin formation in the human endocervix. Clinical and Experimental Immunology 11:219–233
ClarkeD. N.1984; Detection of antispermatozoal antibodies of IgG, IgA and IgM immunoglobulin classes in cervical mucus. American Journal of Reproductive Immunology 6:195–197
CohenG. H.,
DietzscholdB.,
Ponce de LeonM.,
LongD.,
GolubE.,
VarrichioA.,
PereiraL.,
EisenbergR. J.1984; Localization and synthesis of an antigenic determinant of herpes simplex glycoprotein D that stimulates production of neutralizing antibody. Journal of Virology 49:102–107
CzerkinskyC.,
NilssonL.-A.,
NygrenH.,
OuchterlonyO.,
TarkowskiA.1987; IgA antibody-producing cells after antigen ingestion: evidence for a common mucosal immune system in humans. Proceedings of the National Academy of Sciences, U.S.A. 84:2449–2453
CzerkinskyC.,
RussellM. W.,
LyckeN.,
LindbladM.,
HolmgrenJ.1989; Oral administration of a Streptococcus antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infection and Immunity 57:1072–1077
DrewM. D.,
OwenB. D.1988; The provision of passive immunity to colostrum-deprived piglets by bovine or porcine serum immunoglobulins. Canadian Journal of Animal Science 68:1277–1284
EisenbergR. J.,
LongD.,
Hogue-AngelettiR.,
CohenG. H.1984; Amino-terminal sequence of glycoprotein D of herpes simplex virus types 1 and 2. Journal of Virology 49:265–268
ElsonC. O.,
EaldingW.1984; Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. Journal of Immunology 133:2892–2898
ElsonC. O.,
EaldingW.,
LefkowitzJ.1984; A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. Journal of Immunological Methods 61:101–106
EnglerH.,
ZawatzkyR.,
GoldbachA.,
SchrӧderC. H.,
WeyandC.,
HӓmmerlingG. J.,
KirchnerH.1981; Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate. Journal of General Virology 55:25–30
FeenstraV.,
HodaieM.,
JohnsonD. C.1990; Deletions in herpes simplex virus glycoprotein D define non essential and essential domains. Journal of Virology 64:2096–2102
GeerligsH. J.,
WeijerW. J.,
WellingG. W.,
Welling-WesterS.1989; The influence of different adjuvants on the immune response to a synthetic peptide comprising amino acid residues 9-21 of herpes simplex virus type 1 glycoprotein D. Journal of Immunological Methods 124:95–102
Heber-KatzE.,
HollosiM.,
DietzscholdB.,
HudeczF.,
FasmanG. D.1985; The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation. Journal of Immunology 135:1385–1390
JacksonG. D. F.,
Lemaitre-CoelhoI.,
VaermanJ.-P.,
BazinH.,
BeckersA.1978; Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile. European Journal of Immunology 8:123–126
JohnsonD. C.,
BurkeR. L.,
GregoryT.1990; Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells. Journal of Virology 64:2569–2576
KerrW. R.,
RobertsonM.1953; Active and passive sensitization of the uterus of the cow in vivo against Trichomonas fetus antigen and evidence for the local production of antibody in that site. Journal of Hygiene 51:405–415
KikutaK.,
HirabayashiY.,
NagamineT.,
AizawaC.,
UenoY.,
OyaA.,
KurataT.,
TamuraS.-I.1990; Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit. Vaccine 8:595–599
KuttehW. H.,
HatchK. D.,
BlackwellR. E.,
MesteckyJ.1988; Secretory immune system of the female reproductive tract. I. Immunoglobulin and secretory component-containing cells. Obstetrics and Gynecology 71:56–60
LarsenH. S.,
RussellR. G.,
RouseB. T.1983; Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infection and Immunity 41:197–204
LebmanD. A.,
FuhrmanJ. A.,
CebraJ. J.1988; Intraduodenal application of cholera holotoxin increases the potential of clones from Peyer’s patch B cells of relevant and unrelated specificities to secrete IgG and IgA. Regional Immunology 1:32–40
LiangX.,
LammM. E.,
NedrudJ. G.1988; Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. Journal of Immunology 141:1495–1501
LiangX.,
LammM. E.,
NedrudJ. G.1989; Cholera toxin as a mucosal adjuvant: glutaraldehyde treatment dissociated adjuvanti-city from toxicity. Journal of Immunology 143:484–490
LigasM. W.,
JohnsonD. C.1988; A herpes simplex virus mutant in which glycoprotein D sequences are replaced by /1-galactosidase sequences binds to but is unable to penetrate into cells. Journal of Virology 62:1486–1494
LongneckerR.,
ChatterjeeS.,
WhitleyR. J.,
RoizmanB.1987; Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proceedings of the National Academy of Sciences, U.S.A. 84:4303–4307
LyckeN.1986; A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells. Scandinavian Journal of Immunology 24:393–403
LyckeN.,
HolmgrenJ.1986; Strong adjuvant properties of cholera toxin in gut mucosal immune responses to orally presented antigens. Immunology 59:301–308
McDermottM. R.,
BienenstockJ.1979; Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. Journal of Immunology 122:1892–1898
McDermottM. R.,
ClarkD. A.,
BienenstockJ.1980; Evidence for a common mucosal immunologic system. II. Influence of the oestrous cycle on B immunoblast migration into genital and intestinal tissues. Journal of Immunology 124:2536–2539
McDermottM. R.,
SmileyJ. R.,
BraisP. L. J.,
RudzrogaH. E.,
BienenstockJ.1984; Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. Journal of Virology 51:747–753
McDermottM. R.,
BraisP. L. J.,
GoettsheG.,
EveleghM. J.1987; Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes. Archives of Virology 93:51–68
McDermottM. R.,
GoldsmithC. H.,
RosenthalK. L.,
BraisL. J.1989; T. lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. Journal of Infectious Diseases 159:460–466
McDermottM. R.,
BraisL. J.,
EveleghM. J.1990; Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. Journal of General Virology 71:1497–1504
McKenzieS. J.,
HalseyJ. F.1984; Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. Journal of Immunology 133:1818–1824
MarsdenH. S.,
BuckmasterA.,
PalfreymanJ.,
HopeR. G.,
MinsonA. C.1984; Characterization of the 92000 dalton glycoprotein induced by HSV type 2. Journal of Virology 50:547–554
MartinS.,
MossB.,
BermanP. W.,
LaskeyL. A.,
RouseB. T.1987; Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. Journal of Virology 61:726–734
MendisL. N.,
BestJ. M.,
BanatvalaJ. G.1981; Class-specific antibodies (IgG and IgA) to membrane antigens of herpes simplex type-2 infected cells in patients with cervical dysplasia and neoplasia. International Journal of Cancer 27:669–677
MerrinranH.,
WoodsS.,
WinterC.,
FahnlanderA.,
CoreyL.1984; Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus. Journal of Infectious Disease 149:505–510
MesteckyJ.1987; The common mucosal immune system and current strategies for induction of immune response in external secretions. Journal of Clinical Immunology 7:265–269
MesteckyJ.,
McGheeJ. R.,
ArnoldR. R.,
MichalekS. M.,
PrinceS. J.,
BabbJ. L.1978; Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. Journal of Clinical Investigation 61:731–737
NicholsR. L.,
MurrayE. S.,
NissonP. E.1978; Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs. Journal of Infectious Disease 138:742–746
ParrE. L.,
ParrM. B.1990; A comparison of antibody titres in mouse uterine fluid after immunization by several routes, and the effect of the uterus on antibody titres in vaginal fluid. Journal of Reproduction and Fertility 89:619–625
ParrE. L.,
ParrM. B.,
ThaparM.1988; A comparison of specific antibody responses in mouse vaginal fluid after immunization by several routes. Journal of Reproductive Immunology 14:165–176
ParrM. B.,
ParrE. L.1989; Immunohistochemical investigation of secretory component and immunoglobulin A in the genital tract of the female rat. Journal of Reproduction and Fertility 85:105–113
PierceN. F.,
GowansJ. L.1975; Cellular kinetics of the intestinal immune response to cholera toxoid in rats. Journal of Experimental Medicine 142:1550–1563
Plaeger-MarshallS.,
WilsonL. A.,
SmithJ. W.1983; Alteration of rabbit alveolar and peritoneal macrophage function by herpes simplex virus. Infection and Immunity 41:1376–1379
RebelloR.,
GreenF. H. Y.,
FoxH.1975; A study of the secretory immune system of the female reproductive tract. British Journal of Obstetrics and Gynaecology 82:812–816
RichmanD. D.,
BuckmasterA.,
BellS.,
HodgmanC.,
MinsonA. C.1986; Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. Journal of Virology 57:647–655
RoizmanB.,
NorrildB.,
ChanC.,
PereiraL.1984; Identification and primary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology 133:242–247
RosenthallK. L.,
SmileyJ. R.,
SouthS.,
JohnsonD. C.1987; Cells expressing herpes simplex virus glycoprotein gC but not gG, gD or gE are recognized by murine virus-specific cytotoxic T lymphocytes. Journal of Virology 61:2438–2447
SheldrakeR. F.,
HusbandA. J.,
WatsonD. L.,
CrippsA. W.1984; Selective transport of serum-derived IgA into mucosal secretions. Journal of Immunology 132:363–368
ShoreS. L.,
CromeansT. L.,
NorrildB.1979; Early damage of herpes-infected cells by antibody dependent cellular cytotoxicity: relative roles of virus-specified cell surface antigen and input virus. Journal of Immunology 123:2239–2244
StanberryL. R.,
BernsteinD. I.,
BurkeR. L.,
PachlC.,
MyersM. G.1987; Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. Journal of Infectious Diseases 155:914–920
SteineckerF.,
KreuterJ.,
LowerJ.1991; High antibody titers in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines. AIDS 5:431–135
ThaparM. A.,
ParrE. L.,
ParrM. B.1990b; The effect of adjuvants on antibody titers in mouse vaginal fluid after intravaginal immunization. Journal of Reproductive Immunology 17:207–216
TourvilleD. R.,
OgraS. S.,
LippesJ.,
TomasiT. B.1970; The human female reproductive tract: immunohistological localization of tA, tG, tM, secretory ‘piece,’ and lactoferrin. American Journal of Obstetrics and Gynecology 108:1102–1108
WaldmanR. H.,
CruzJ. M.,
RoweD. S.1971; Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions. Clinical and Experimental Immunology 10:427–434
WalzM. A.,
PriceR. W.,
NotkinsA. L.1974; Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science 184:1175–1187
WatariE.,
DietzscholdB.,
SzokanG.,
Heber-KatzE.1987; A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2. Journal of Experimental Medicine 165:459–466
Weisz-CarringtonP.,
RouxM. E.,
McWilliamsM.,
Phillips-QuagliataJ. M.,
LammM. E.1979; Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system. Journal of Immunology 123:1705–1708